2-153712244-G-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001422879.1(GALNT13):c.-238-20525G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.517 in 152,020 control chromosomes in the GnomAD database, including 24,522 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.52 ( 24522 hom., cov: 32)
Consequence
GALNT13
NM_001422879.1 intron
NM_001422879.1 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.525
Publications
10 publications found
Genes affected
GALNT13 (HGNC:23242): (polypeptide N-acetylgalactosaminyltransferase 13) The GALNT13 protein is a member of the UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase (GalNAcT; EC 2.4.1.41) family, which initiate O-linked glycosylation of mucins (see MUC3A, MIM 158371) by the initial transfer of N-acetylgalactosamine (GalNAc) with an alpha-linkage to a serine or threonine residue.[supplied by OMIM, Apr 2004]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.692 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| GALNT13 | NM_001422879.1 | c.-238-20525G>C | intron_variant | Intron 2 of 15 | NP_001409808.1 | |||
| GALNT13 | NM_001422880.1 | c.-238-20525G>C | intron_variant | Intron 2 of 14 | NP_001409809.1 | |||
| GALNT13 | NM_001422881.1 | c.-238-20525G>C | intron_variant | Intron 1 of 13 | NP_001409810.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|
Frequencies
GnomAD3 genomes AF: 0.517 AC: 78600AN: 151902Hom.: 24521 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
78600
AN:
151902
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.517 AC: 78607AN: 152020Hom.: 24522 Cov.: 32 AF XY: 0.518 AC XY: 38481AN XY: 74328 show subpopulations
GnomAD4 genome
AF:
AC:
78607
AN:
152020
Hom.:
Cov.:
32
AF XY:
AC XY:
38481
AN XY:
74328
show subpopulations
African (AFR)
AF:
AC:
7821
AN:
41466
American (AMR)
AF:
AC:
8866
AN:
15264
Ashkenazi Jewish (ASJ)
AF:
AC:
2334
AN:
3470
East Asian (EAS)
AF:
AC:
545
AN:
5170
South Asian (SAS)
AF:
AC:
2022
AN:
4810
European-Finnish (FIN)
AF:
AC:
7599
AN:
10582
Middle Eastern (MID)
AF:
AC:
180
AN:
294
European-Non Finnish (NFE)
AF:
AC:
47368
AN:
67940
Other (OTH)
AF:
AC:
1150
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1513
3025
4538
6050
7563
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
650
1300
1950
2600
3250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
977
AN:
3468
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.